| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 08/08/2013 | WO2013071038A3 Antagonists for abnormal vasopressin v2 receptor and uses thereof |
| 08/08/2013 | WO2013066944A3 Biomarkers for cancer characterization and treatment |
| 08/08/2013 | WO2013021129A3 Use of a cb1 receptor antagonist as a whitening and/or anti-browning agent for keratin material |
| 08/08/2013 | US20130204069 Compositions and Methods of Treating Tumors |
| 08/08/2013 | US20130203977 Oligonucleotides comprising alternating segments and uses thereof |
| 08/08/2013 | US20130203961 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 08/08/2013 | US20130203851 Use of 2,5-Dihydroxybenzenesulfonic Acid in the Manufacturing of Medicines, Applicable to the Treatment of Angiodependent Diseases |
| 08/08/2013 | US20130203700 Cyclodextrin-based polymers for therapeutics delivery |
| 08/08/2013 | US20130202689 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| 08/08/2013 | US20130202663 Remedy |
| 08/08/2013 | US20130202552 Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins |
| 08/08/2013 | CA2861377A1 Combination of a rtk inhibitor with an anti - estrogen and use thereof for the treatment of cancer |
| 08/08/2013 | CA2856618A1 Negatively charged nucleic acid comprising complexes for immunostimulation |
| 08/08/2013 | CA2856615A1 Pharmaceutical composition comprising a polymeric carrier cargo complex and at least one protein or pepide antigen |
| 08/08/2013 | CA2848985A1 C10rf32 antibodies, and uses thereof for treatment of cancer |
| 08/07/2013 | EP2623600A1 Inhibitor of expression of dominantly mutated gene |
| 08/07/2013 | EP2623594A1 Antibody against human prostaglandin e2 receptor ep4 |
| 08/07/2013 | EP2623493A1 N-(hetero)aryl,2-(hetero)aryl-substituted acetamides for use as WNT signaling modulators |
| 08/07/2013 | EP2623491A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 08/07/2013 | EP2623107A1 Arctigenin-containing bardanae fructus extract and method for producing same |
| 08/07/2013 | EP2623105A2 Modulation of line-1 reverse transcriptase |
| 08/07/2013 | EP2623098A1 Amide Amino Acid Esters of Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) as Potent Inhibitors of Colon Tumor Cell Growth |
| 08/07/2013 | EP2622076A1 Treatment of b-cell lymphoma with microrna |
| 08/07/2013 | EP2621955A1 Anti-ceacam6 antibodies and uses thereof |
| 08/07/2013 | EP2621954A1 Anti-rori antibodies |
| 08/07/2013 | EP2621945A2 Nd2 peptides and methods of treating neurological disease |
| 08/07/2013 | EP2621929A1 Novel acridine derivatives |
| 08/07/2013 | EP2621928A1 7-hydroxy-pyrazolo[1,5-a]pyrimidine compounds and their use as ccr2 receptor antagonists |
| 08/07/2013 | EP2621925A1 Fused tricyclic inhibitors of mammalian target of rapamycin |
| 08/07/2013 | EP2621919A1 Phenylquinazoline derivatives |
| 08/07/2013 | EP2621913A1 Substituted benzimidazole and imidazopyridine compounds useful as cyp17 modulators |
| 08/07/2013 | EP2621904A2 Compounds as c-met kinase inhibitors |
| 08/07/2013 | EP2621588A2 Methods and compositions for disease treatment using inhalation |
| 08/07/2013 | EP2621539A1 Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers |
| 08/07/2013 | EP2621536A1 Amatoxin-conjugates with improved linkers |
| 08/07/2013 | EP2621535A1 Thiazolidine linker for the conjugation of drugs to antibodies |
| 08/07/2013 | EP2621531A1 Anti-cd38 antibody and lenalidomide or bortezomib for the treatment of multiple myeloma and nhl |
| 08/07/2013 | EP2621516A2 Interferon-beta for use as monotherapy or in combination with other cancer therapies |
| 08/07/2013 | EP2621514A1 Compositions and methods for treatment of hematological malignancies |
| 08/07/2013 | EP2621509A2 Formulations of guanylate cyclase c agonists and methods of use |
| 08/07/2013 | EP2621500A2 Therapeutic use of a tlr agonist and combination therapy |
| 08/07/2013 | EP2621489A1 Combinations of 4-(cyclopropylamino)-2-(4-(4-(ethylsulfonyl)piperazin-1-yl)phenylamino)pyrimidine-5-carboxamide and fludarabine |
| 08/07/2013 | EP2621486A1 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations |
| 08/07/2013 | EP2621483A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 08/07/2013 | EP2621482A1 Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases |
| 08/07/2013 | EP2621481A1 Dual inhibitors of met and vegf for the treatment of castration- resistant prostate cancer and osteoblastic bone metastases |
| 08/07/2013 | EP2621478A2 Method of preparing a dry powder from a water bacteria extract-concentrate |
| 08/07/2013 | EP2621275A1 Aryl-substituted imidazoles |
| 08/07/2013 | EP2621273A2 Polyphosphate and pyrophosphate derivative of saccharides |
| 08/07/2013 | CN1515244B Protein-stable pharmacological active matter, its preparation and application method |
| 08/07/2013 | CN103237811A Compositions and methods of use for therapeutic low density lipoprotein-related protein 6 (LPR6) multivalent antibodies |
| 08/07/2013 | CN103237808A 抗癌融合蛋白 Anticancer fusion protein |
| 08/07/2013 | CN103237803A Triazolopyridine compounds |
| 08/07/2013 | CN103237801A Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 08/07/2013 | CN103237799A Heterocyclic derivates, preparation processes and medical uses thereof |
| 08/07/2013 | CN103237798A Substituted benzimidazole and imidazopyridine compounds used as CYP17 modulators |
| 08/07/2013 | CN103237797A Quinolin-4 (1h)-ketone derivatives as inhibitors of phosphatidylinositol 3-kinases |
| 08/07/2013 | CN103237793A Pyrazole compound having therapeutic effect on multiple myeloma |
| 08/07/2013 | CN103237544A Pharmaceutical compositions |
| 08/07/2013 | CN103233009A Application of substance capable of reducing expression of zinc finger protein CTCF to preparation of drugs for treating leukemia |
| 08/07/2013 | CN103233007A Hsa-miR-545miRNA and use thereof |
| 08/07/2013 | CN103232976A Medium supplement for virus production |
| 08/07/2013 | CN103232973A Method for amplification and activation of NK cells by K562 cells |
| 08/07/2013 | CN103232543A Recombinant protein Tumstatin-CD137L4 with Tumstatin activities as well as preparation method and application thereof |
| 08/07/2013 | CN103232540A Domain antibody construct |
| 08/07/2013 | CN103232539A Antibodies to opgl |
| 08/07/2013 | CN103232537A Preparation method and use of mustelus griseus cartilage blood vessel generation inhibiting factor |
| 08/07/2013 | CN103232531A Cancer cell-targeting structural molecule and use thereof |
| 08/07/2013 | CN103232521A Tanshinone imidazole compound and its preparation method and use |
| 08/07/2013 | CN103232520A Spirosteroid compounds and preparation method and medical application thereof |
| 08/07/2013 | CN103232518A New salicornia bigelovii torr nortriterpenoid saponin compound, preparation method and uses thereof |
| 08/07/2013 | CN103232509A Fluorouracil compound, and preparation method and application thereof |
| 08/07/2013 | CN103232474A Histone deacetylase inhibitors |
| 08/07/2013 | CN103232464A Paclitaxel-like compounds, and preparation method thereof and application thereof in anticancer mediciens |
| 08/07/2013 | CN103232443A Indazole derivative crystal and its preparation method and use |
| 08/07/2013 | CN103232440A Preparation method and application of sym-triazole bi-Schiff base compound |
| 08/07/2013 | CN103232439A N-heterocyclic methyl tetrahydropyridine-5-substituted indole and preparation method and application thereof |
| 08/07/2013 | CN103232433A N-substituted benzyl tetrahydropyridine with indole and preparation method and application thereof |
| 08/07/2013 | CN103232427A Xanthone compound as well as preparation method and application thereof |
| 08/07/2013 | CN103232422A A light-sensitive expansionary polymer and a preparation method and applications thereof |
| 08/07/2013 | CN103232420A Zedoary turmeric lactone enantiomer and preparation method thereof |
| 08/07/2013 | CN103232406A 1, 3-thiazole derivative |
| 08/07/2013 | CN103232394A Pyrazole-containing compound as well as preparation method and use thereof |
| 08/07/2013 | CN103232378A Dog whelk extract containing 6-bromo-1H-indole-2, 3-dione, preparation method thereof and anti-caner application thereof |
| 08/07/2013 | CN103232374A Side-chain aromatic ring-modified active vitamin D3 analog, as well as preparation method and application thereof |
| 08/07/2013 | CN103232350A Acylated Danshensu derivative and application thereof to preventing and treating cerebrovascular and liver and kidney diseases |
| 08/07/2013 | CN103230605A Targeted micro-bubble contrast agent and preparation method thereof |
| 08/07/2013 | CN103230604A Magnetic water-soluble fullerene, and preparation method and application thereof |
| 08/07/2013 | CN103230603A Preparation method of EX527 targeted multifunctional mesoporous silicon nano particle |
| 08/07/2013 | CN103230601A Rare earth doped gallium oxide drug-loading body preparation method |
| 08/07/2013 | CN103230600A HBx-modified liver-cancer-inhibiting whole-cell vaccine, and preparation method and application thereof |
| 08/07/2013 | CN103230596A Gold nanometer medicament carrier with synergistic antineoplastic effect |
| 08/07/2013 | CN103230592A Composition of statin medicine and 5-methyltetrahydrofolic acid, and application thereof |
| 08/07/2013 | CN103230591A Medicament for treating liver cancer and application of JARID2 monoclonal antibody |
| 08/07/2013 | CN103230587A Composition of crocodile hemoglobin peptide and preparation method of composition |
| 08/07/2013 | CN103230559A Traditional Chinese medicine composition and preparation method thereof |
| 08/07/2013 | CN103230556A Traditional Chinese medicine for treating cirrhosis and liver cancer and preparation method thereof |
| 08/07/2013 | CN103230496A Traditional Chinese medicine extract and preparation method thereof |
| 08/07/2013 | CN103230495A Phlegmatic hygrosis type obstruction treatment traditional Chinese medicine composition |
| 08/07/2013 | CN103230490A Traditional Chinese medicine pulvis for treating liver neoplasms |